Combined effects of the bisphosphonate, zoledronic acid and the aromatase inhibitor letrozole on breast cancer cells in vitro: evidence of synergistic interaction

Neville-Webbe, H.L., Coleman, R.E. orcid.org/0000-0002-4275-1043 and Holen, I. orcid.org/0000-0002-8759-6913 (2010) Combined effects of the bisphosphonate, zoledronic acid and the aromatase inhibitor letrozole on breast cancer cells in vitro: evidence of synergistic interaction. British Journal of Cancer, 102. pp. 1010-1017. ISSN 0007-0920

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
Keywords: Zoledronic acid; letrozole; apoptosis; synergy; breast cancer
Dates:
  • Published (online): 16 February 2010
  • Accepted: 26 January 2010
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology (Sheffield)
The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 18 Apr 2016 08:42
Last Modified: 18 Apr 2016 08:42
Published Version: http://dx.doi.org/10.1038/sj.bjc.6605579
Status: Published
Publisher: Cancer Research UK
Refereed: Yes
Identification Number: https://doi.org/10.1038/sj.bjc.6605579

Share / Export

Statistics